These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 21431990

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [The effect of botulinum A toxin repeated injection in treating blepharospasm and hemifacial spasm].
    Wang J, Zhang X.
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Apr; 20(7):292-4. PubMed ID: 16780139
    [Abstract] [Full Text] [Related]

  • 5. The validation of the disease-specific questionnaire for health-related quality of life in Thai patients with hemifacial spasm.
    Setthawatcharawanich S, Aui-aree N, Limapichart K, Satirapunya P, Phabphal K.
    J Med Assoc Thai; 2008 Nov; 91(11):1691-7. PubMed ID: 19127791
    [Abstract] [Full Text] [Related]

  • 6. Use of botulinum toxin A in the treatment of hemifacial spasm and blepharospasm.
    Chang LB, Tsai CP, Liao KK, Kao KP, Yuan CL, Yen DJ, Lin KP.
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jan; 62(1):1-5. PubMed ID: 10063705
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of stigmatization in hemifacial spasm and quality of life before and after botulinum toxin treatment.
    Yuksel B, Genc F, Yaman A, Goksu EO, Ak PD, Gomceli YB.
    Acta Neurol Belg; 2019 Mar; 119(1):55-60. PubMed ID: 30178181
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Validation of a Chinese version of disease specific quality of life scale (HFS-36) for hemifacial spasm in Taiwan.
    Huang YC, Fan JY, Ro LS, Lyu RK, Chang HS, Chen ST, Hsu WC, Chen CM, Wu YR.
    Health Qual Life Outcomes; 2009 Dec 24; 7():104. PubMed ID: 20034399
    [Abstract] [Full Text] [Related]

  • 17. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
    Ababneh OH, Cetinkaya A, Kulwin DR.
    Clin Exp Ophthalmol; 2014 Apr 24; 42(3):254-61. PubMed ID: 23844601
    [Abstract] [Full Text] [Related]

  • 18. Treatment outcome correlates with knowledge of disease in hemifacial spasm.
    Tan EK, Hameed S, Fook-Chong S, Hussein K, Lum SY, Chan LL.
    Clin Neurol Neurosurg; 2008 Sep 24; 110(8):813-7. PubMed ID: 18583029
    [Abstract] [Full Text] [Related]

  • 19. Which factors impact on quality of life for adults with blepharospasm and hemifacial spasm?
    Lawes-Wickwar S, McBain H, Hirani SP, Hurt CS, Dunlop N, Solly D, Crampton B, Newman SP, Ezra DG.
    Orbit; 2021 Apr 24; 40(2):110-119. PubMed ID: 32116098
    [Abstract] [Full Text] [Related]

  • 20. Factors affecting the quality of life in hemifacial spasm patients.
    Rudzińska M, Wójcik M, Malec M, Grabska N, Szubiga M, Hartel M, Szczudlik A.
    Neurol Neurochir Pol; 2012 Apr 24; 46(2):121-9. PubMed ID: 22581593
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.